NYTech
Companies
Companyhealthcare ai

PreciseDx

PreciseDx® is innovating oncology diagnostics, leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven, disease analysis. Combining AI with our patented Morphology Feature Array® (MFA), PreciseDx provides access to unmatched disease insights and accurate, actionable intelligence for more comprehensive decision-making throughout the cancer care continuum.[1][2]

Visit website Suggest an update
2020 Founded

Overview

PreciseDx is an artificial intelligence company operating in the New York City healthcare sector [1]. Founded in 2020, the company focuses on oncology diagnostics [2]. PreciseDx leverages artificial intelligence for morphology-driven disease analysis, utilizing a proprietary technology called Morphology Feature Array (MFA) [2]. According to company information, the platform provides disease insights and actionable intelligence to support decision-making across the cancer care continuum [2]. The company operates in the medical and diagnostic laboratories industry [3] and employs 28 people [3].

Business address: 810 7th Ave, New York, New York, 10019. [6]

Growth & traction

LinkedIn lists 28 people working at PreciseDx. [4]

Focus

  • PreciseDx describes itself as "Innovating breast cancer diagnostic testing with PreciseBreast®. That's OncoIntelligence.".[5]

Something wrong or missing? Send an update. Fixed within 24 hours.